Nagoya, Japan

Masato Shimojo

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2006-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masato Shimojo. Retrieved from https://idiyas.com/inventor/masato-shimojo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Aichi, JP (2006)
  • Nagoya, JP (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masato Shimojo: Innovator in IL-6 Involved Diseases Treatment

Introduction

Masato Shimojo is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of diseases involving interleukin-6 (IL-6). His innovative work has led to the development of new therapeutic methods that utilize EP4 receptor ligands.

Latest Patents

Masato Shimojo holds 2 patents related to his research. His latest patents include:

1. Use of EP4 receptor ligands in the treatment of IL-6 involved diseases - Methods of treating IL-6 involved diseases with EP4 receptor ligands, including EP4 receptor antagonists.

2. Assays to determine the effect of test compounds on PGE2-induced whole blood cells activation.

Career Highlights

Shimojo has established himself as a key figure in pharmaceutical innovation. He is currently associated with Pfizer Corporation, where he continues to advance research in his area of expertise. His work has the potential to significantly impact the treatment of various inflammatory diseases.

Collaborations

Masato Shimojo collaborates with several professionals in his field, including his coworker Kana Taniguchi. Their combined efforts contribute to the ongoing research and development of effective treatments.

Conclusion

Masato Shimojo's contributions to the treatment of IL-6 involved diseases highlight his role as an influential inventor in the medical field. His innovative patents and ongoing research at Pfizer Corporation demonstrate his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…